AXDX
Accelerate Diagnostics Inc
NASDAQ: AXDX · HEALTHCARE · MEDICAL DEVICES
$0.03
+0.00% today
Updated 2026-04-29
Market cap
$859920.00
P/E ratio
—
P/S ratio
0.07x
EPS (TTM)
$-2.15
Dividend yield
—
52W range
$0 – $1
Volume
—
Accelerate Diagnostics Inc (AXDX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-4.5%
Last 4 quarters
Revenue YoY growth
-6.1%
Most recent quarter
EPS YoY growth
+54.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2024-12-31 | $-0.50 | $-0.37 | +26.0% | $2.82M | -6.1% |
| 2024-09-30 | $-0.47 | $-0.59 | -25.5% | $2.98M | -9.8% |
| 2024-06-30 | $-0.55 | $-0.53 | +3.6% | $2.99M | +2.2% |
| 2024-03-31 | $-0.72 | $-0.88 | -22.2% | $2.92M | +3.9% |
| 2023-12-31 | $-0.62 | $-0.81 | -30.6% | $3.00M | +0.9% |
| 2023-09-30 | $-1.07 | $0.14 | +113.1% | $3.30M | +11.5% |
| 2023-06-30 | $-1.40 | $-1.31 | +6.4% | $2.92M | -24.3% |
| 2023-03-31 | $-0.14 | $-0.17 | -21.4% | $2.81M | — |
| 2022-12-31 | $-0.15 | $-0.14 | +6.7% | $2.97M | — |
| 2022-09-30 | $-0.19 | $-0.18 | +5.3% | $2.96M | — |
| 2022-06-30 | $-0.28 | $-0.23 | +17.9% | $3.86M | — |
| 2022-03-31 | $-0.30 | $-0.21 | +30.0% | — | — |
| 2021-12-31 | $-0.25 | $-0.35 | -40.0% | — | — |
Frequently asked questions
Has Accelerate Diagnostics Inc beaten earnings estimates?
Accelerate Diagnostics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -4.5% over the last 4 quarters.
What is Accelerate Diagnostics Inc's revenue growth rate?
Accelerate Diagnostics Inc reported year-over-year revenue growth of -6.1% in its most recent quarter, with EPS growing +54.3% year-over-year.